Marjorie Pick

1.7k total citations
52 papers, 1.4k citations indexed

About

Marjorie Pick is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Marjorie Pick has authored 52 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 18 papers in Hematology and 13 papers in Oncology. Recurrent topics in Marjorie Pick's work include Cholinesterase and Neurodegenerative Diseases (9 papers), Multiple Myeloma Research and Treatments (8 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers). Marjorie Pick is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (9 papers), Multiple Myeloma Research and Treatments (8 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers). Marjorie Pick collaborates with scholars based in Israel, United States and Australia. Marjorie Pick's co-authors include Varda Deutsch, Hermona Soreq, Amiram Eldor, Dan Grisaru, Andrew G. Elefanty, Edouard G. Stanley, Lisa Azzola, Nissim Benvenisty, Chava Perry and Amir Eden and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Marjorie Pick

52 papers receiving 1.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Marjorie Pick 700 341 288 217 170 52 1.4k
Matthew T. Harper 702 1.0× 775 2.3× 49 0.2× 196 0.9× 232 1.4× 77 2.0k
Lin Zou 509 0.7× 118 0.3× 62 0.2× 89 0.4× 91 0.5× 73 1.1k
Stefano Ratti 863 1.2× 124 0.4× 75 0.3× 83 0.4× 109 0.6× 103 1.5k
Linda Taylor 658 0.9× 126 0.4× 172 0.6× 402 1.9× 193 1.1× 67 1.5k
El‐Bdaoui Haddad 427 0.6× 61 0.2× 136 0.5× 158 0.7× 358 2.1× 39 1.5k
Pamela Ehrenfeld 457 0.7× 78 0.2× 37 0.1× 362 1.7× 252 1.5× 68 1.2k
John M. Ong 632 0.9× 67 0.2× 50 0.2× 129 0.6× 223 1.3× 24 1.4k
Cindy Wang 464 0.7× 140 0.4× 66 0.2× 166 0.8× 57 0.3× 49 1.2k
J.R. Connor 431 0.6× 99 0.3× 135 0.5× 38 0.2× 122 0.7× 17 1.1k
J. Kawagoe 710 1.0× 498 1.5× 66 0.2× 259 1.2× 149 0.9× 37 1.6k

Countries citing papers authored by Marjorie Pick

Since Specialization
Citations

This map shows the geographic impact of Marjorie Pick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjorie Pick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjorie Pick more than expected).

Fields of papers citing papers by Marjorie Pick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjorie Pick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjorie Pick. The network helps show where Marjorie Pick may publish in the future.

Co-authorship network of co-authors of Marjorie Pick

This figure shows the co-authorship network connecting the top 25 collaborators of Marjorie Pick. A scholar is included among the top collaborators of Marjorie Pick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjorie Pick. Marjorie Pick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pick, Marjorie, Sharona Elgavish, Hadar Benyamini, et al.. (2023). Amyloidogenic light chains impair plasma cell survival. Haematologica. 108(12). 3359–3371. 2 indexed citations
2.
Kfir‐Erenfeld, Shlomit, Batia Avni, Sigal Grisariu, et al.. (2023). Safety and Efficacy of a Locally Produced Novel Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) (HBI0101) for the Treatment of Relapsed and Refractory Multiple Myeloma. Blood. 142(Supplement 1). 4852–4852. 1 indexed citations
3.
Kfir‐Erenfeld, Shlomit, Sigal Grisariu, Batia Avni, et al.. (2022). Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis. Clinical Cancer Research. 28(23). 5156–5166. 21 indexed citations
4.
Kfir‐Erenfeld, Shlomit, Batia Avni, Miri Assayag, et al.. (2022). Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial. Haematologica. 108(7). 1827–1839. 17 indexed citations
5.
Gatt, Moshe E., et al.. (2016). The role of CD24 in multiple myeloma tumorigenicity and the effect of the microenvironment on CD24 expression. Experimental Hematology. 44(9). S75–S75. 1 indexed citations
6.
Gatt, Moshe E., Kohichi Takada, Mala Mani, et al.. (2013). TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity. British Journal of Haematology. 162(2). 210–220. 24 indexed citations
7.
Pick, Marjorie. (2013). Generation of Megakaryocytes and Platelets from Human Pluripotent Stem Cells. Methods in molecular biology. 1307. 371–378. 1 indexed citations
8.
Mor, Inbal, Ella H. Sklan, Erez Podoly, et al.. (2008). Acetylcholinesterase‐R increases germ cell apoptosis but enhances sperm motility. Journal of Cellular and Molecular Medicine. 12(2). 479–495. 31 indexed citations
9.
Perry, Chava, Marjorie Pick, Erez Podoly, et al.. (2007). Acetylcholinesterase/C terminal binding protein interactions modify Ikaros functions, causing T lymphopenia. Leukemia. 21(7). 1472–1480. 24 indexed citations
10.
Grisaru, Dan, Marjorie Pick, Chava Perry, et al.. (2006). Hydrolytic and Nonenzymatic Functions of Acetylcholinesterase Comodulate Hemopoietic Stress Responses. The Journal of Immunology. 176(1). 27–35. 55 indexed citations
11.
Pick, Marjorie, Chava Perry, Tsvee Lapidot, et al.. (2005). Stress-induced cholinergic signaling promotes inflammation-associated thrombopoiesis. Blood. 107(8). 3397–3406. 46 indexed citations
12.
Pick, Marjorie, César Flores‐Flores, & Hermona Soreq. (2004). From Brain to Blood: Alternative Splicing Evidence for the Cholinergic Basis of Mammalian Stress Responses. Annals of the New York Academy of Sciences. 1018(1). 85–98. 36 indexed citations
13.
Deutsch, Varda, Marjorie Pick, Chava Perry, et al.. (2002). The stress-associated acetylcholinesterase variant AChE-R is expressed in human CD34+ hematopoietic progenitors and its C-terminal peptide ARP promotes their proliferation. Experimental Hematology. 30(10). 1153–1161. 59 indexed citations
14.
Pick, Marjorie, et al.. (2002). Ex vivo expansion of megakaryocyte progenitors from cryopreserved umbilical cord blood. Experimental Hematology. 30(9). 1079–1087. 15 indexed citations
15.
Harris, N., Marjorie Pick, V Deutsch, et al.. (1998). c-K-ras transformed rat enterocytes (R1) are more sensitive than normal enterocytes (IEC18) to growth inhibition and appptosis-induced by sulindac sulfone and nimesulid. Gastroenterology. 114. A607–A607. 3 indexed citations
16.
Pick, Marjorie, Arnon Nagler, Dan Grisaru, Amiram Eldor, & Varda Deutsch. (1998). Expansion of megakaryocyte progenitors from human umbilical cord blood using a new two‐step separation procedure. British Journal of Haematology. 103(3). 639–650. 24 indexed citations
17.
Ruf, Andreas, Marjorie Pick, Varda Deutsch, et al.. (1997). In‐vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with β‐thalassaemia major. British Journal of Haematology. 98(1). 51–56. 115 indexed citations
18.
Sela‐Donenfeld, Dalit, Mira Korner, Marjorie Pick, Amiram Eldor, & Amos Panet. (1996). Programmed Endothelial Cell Death Induced by an Avian Hemangioma Retrovirus Is Density Dependent. Virology. 223(1). 233–237. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026